CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 17,544 shares at $3.49 ($61,144)
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 33,150 shares (option exercise)
- 4 Option exercise Director acquired 33,150 shares (option exercise)
- 4 Option exercise Director acquired 33,150 shares (option exercise)
- 4 Option exercise Director acquired 33,150 shares (option exercise)
- 4 Option exercise Director acquired 33,150 shares (option exercise)
- 4 Option exercise Director acquired 33,150 shares (option exercise)
- 4 Planned sale President, CEO, and Chairman sold 1,006 shares at $4.00 ($4,024)
- 144 Insider Sale of Securities
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
Page 6 of 16 · 316 filings